CVS Health Completes $70 Billion Acquisition of Aetna, Ushering in a New Integrated Healthcare Model
Image source: CVS Health official website
VCBeat (WeChat: vcbeat) has learned from foreign media that U.S. pharmaceutical retail giant CVS Health (hereinafter referred to as CVS) announced on November 28 (local time) that it had completed the final approval step for its acquisition of health insurer Aetna. With this, the $70 billion deal—the largest acquisition in the history of the U.S. pharmaceutical retail industry—has finally been settled after a year-long process.
This deal is not only the most high-profile and controversial M&A transaction of the year, but also a key focus for VCBeat. Below, we outline several key details of this merger and acquisition:
1. Pursuant to the terms of the agreement, CVS will acquire each outstanding share of Aetna for $145 in cash and 0.8378 shares of CVS stock, representing a combined value of $212 per share and a total transaction value of $70 billion. CVS will not issue any fractional shares in the transaction. The transaction will be financed through cash and debt financing, including the issuance of $40 billion in senior notes and two tranches of $5 billion term loans.
2. Upon completion of the acquisition, Aetna will operate as an independent unit within CVS Health, and the Aetna brand name will continue to be used for its health insurance products. Aetna will retain its existing management team.
3. As a condition for the acquisition, CVS will adhere to the agreement it reached with the U.S. Department of Justice (DOJ) in October, allowing Aetna to sell its Medicare Part D prescription drug plans to WellCare Health Plans, based in Tampa, Florida. The transaction is expected to be completed within the next few business days. Under the agreement, WellCare will take over this business, which serves 2.2 million members, on December 31 of this year.
4. The merged company, known as CVS Health, is listed on the New York Stock Exchange under the ticker symbol “CVS.” It has begun building a new healthcare model and plans to launch chronic disease management programs in the near term through its MinuteClinics division. Other new services the company intends to introduce include preventive health screenings for communities at higher risk of certain health conditions, as well as initiatives aimed at improving medication adherence and reducing healthcare costs associated with unnecessary emergency room visits.
5. According to Larry Merlo, President and CEO of CVS Health, the merged CVS Health will adopt a community-focused approach, fully integrating Aetna’s strengths in healthcare data and analytics with CVS’s pharmacy data to simplify the complex healthcare system and enable consumers to access the care they need, anytime and anywhere. The company anticipates that patients will benefit from earlier interventions and better-coordinated care, leading to improved health outcomes and reduced medical costs.
This is largely consistent with the statements made by CVS and Aetna when they announced their partnership last year. However, since the deal was initiated last year, it has been mired in controversy. Some industry insiders, including the American Medical Association (AMA), maintain that the transaction will harm consumers’ interests. Others argue that vertical integration across the industry’s upstream and downstream sectors is an inevitable trend as the industry matures to a certain stage.
Although the year-long acquisition process has finally concluded, its impact on the industry is only just beginning. VCBeat will continue to closely monitor this newly merged “super company.”